# Webinar Recap: Reasons I'm Excited About Simplify Genomics | Simplify Genomics

- Canonical URL: https://wefunder.com/feed/366302
- Entity ID: wefunder:feed_item:366302
- Published at: 2026-08-10 17:42:28 UTC
- Updated at: 2026-08-10 22:40:23 UTC

## Author
Travis Lacey

## Subject
Simplify Genomics

## Content
In 30 years in healthcare, I don't think I've ever been more excited about what's ahead for Simplify Genomics. Last week, I had the opportunity to walk through why on a live webinar. If you missed it, here's the full recording.For anyone who doesn't have 50 minutes, here's the recap.The timing has flipped. For years the conversation with health systems and physicians was "genomics is important, but we're not sure we're ready." That's completely reversed. Now it's "how fast can we get this in front of patients and clients." We didn't have to convince the market. The market caught up to us.Our growth has come entirely from word of mouth. We've grown from a handful of concierge and executive health practices to 15+ customers without any real marketing or sales spend. Physicians are recommending us to other physicians.We built this to be capital-efficient. Every report we sell is profitable from day one. We designed this business to make money while it grows.Partnerships are turning into real distribution. Our partnership with SimonMed is publicly announced, and their sales force will be selling our report alongside their whole-body MRI service. We're in active discussions with several other organizations that already have the customer relationships we'd otherwise have to build from scratch, including an advanced conversation with a major technology partner. We will keep you posted as these conversations progress.We've stayed disciplined on the science and regulatory compliance, and it's paying off. We're CAP-accredited and CLIA-certified, and we've avoided shortcuts that would've grown revenue faster but weren't compliant. Physicians tell us we find things other labs miss. That discipline matters even more as more "genomic tests" enter the market without the same rigor and responsibility behind them.We also took live investor questions on everything from our competitive moat, to international expansion, to how AI fits into the business, so be sure to watch till the end of the recording for more of those details.If you've been thinking about this round, now's a good time to check where you stand on accreditation and reach out with any questions: investors@simplifygenomics.com.— TravisThis bridge round is currently open to accredited investors. Not sure if that's you? Here's WeFunder's guide to accreditation and the link to verify your status. Once verified or if you get stuck, reach out to investors@simplifygenomics.com, comment below, or book a call — we'll get you the details.